Masonic Cancer Center, University of Minnesota

 

Print this page. Mail this link to a friend.

Masonic Cancer Center research to be presented at annual ASH meeting

(December 1, 2008) Many Masonic Cancer Center researchers and University of Minnesota colleagues will be among the presenters at the American Society of Hematology (ASH) meeting December 6-9, 2008, in San Francisco.

If you or someone from your laboratory is giving an oral or poster presentation at ASH, and you have not been listed yet, please e-mail Sandi Sherman, sherm019@umn.edu, with your name, title and/or lab affiliation, and the title of your presentation to be included on the list and in a future edition of Update.

Oral Presentations

  • Ashish Kumar, M.D., Ph.D., "A MEIS1 Dependent Genetic Program in leukemia associated with cell cycle entry and 'stemness' " (selected Best of ASH); and "Evi1 promotes leukemogenesis by anti-apoptotic rather than differentiation-blocking effects in murine MLL-AF9 leukemia" See related news release.
  • Brian McClune, D.O.: "Non-myeloablative hematopoietic stem cell transplantation in older patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)" See related news release.
  • Sarah Cooley, M.D.: "Successful haploidentical hematopoietic cell engraftment using a non-myeloablative preparative regimen including natural killer (NK) cells"
  • Claudio Brunstein, M.S., Ph.D.: "Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplantation depends on transplantation conditioning intensity"
  • Pamala Jacobson, Pharm.D.: "Fludarabine exposure and treatment related mortality"
  • Jakub Tolar, M.D., Ph.D.: "Patient-specific induced pluripotent stem cells in Hurler syndrome"
  • Bartosz Grzywacz, Ph.D.: "Identification of a myeloid pathway of NK cell development and a myeloid-NK cell precursor"
  • Marcie Tomblyn, M.D., M.S.: "Decreased infections in recipients of unrelated donor (URD) hematopoietic cell transplantation (HCT) from donors with an activating KIR B genotype (B/x)"
  • Frank Cichocki: "Antisense transcripts negatively regulate transcription of multiple variegated killer immunoglobulin-like receptor (KIR) genes."
  • Katherine Hill, Kaufman lab: "In vitro and in vivo characterization of human embryonic stem cell- derived CD34+ cells that function as pericytes with endothelial cell and smooth muscle cell potential"
  • Xinghui Tian, Ph.D., Kaufman lab: "Human embryonic stem cell-derived CD34+ cells preferentially develop into endothelial cells when transplanted into neonatal immunodeficient mice"

Poster Presentations

  • Claudio Brunstein, M.D., Ph.D.: "Favorable leukemia-free survival (LFS) for adults and children undergoing myeloablative umbilical cord blood (UCB) transplantation with cyclophosphamide (CY), fludarabine (FLU) and total body irradiation (TBI): A single center analysis of 194 patients"
  • Robert Godal, Miller lab: "Blocking inhibitory KIR is insufficient for optimal killing of AML and ALL targets: additional requirements for NKG2A and LIR-1 blockade"
  • Xueqing Liang, M.D., Ph.D.: "Toll-like receptor-7 agonist directly inhibits the growth and induces apoptosis of MLL-AF9 leukemia cells"
  • Margaret MacMillan, M.D.: "Alternate donor HCT for Fanconi Anemia (FA): Results of a total body irradiation (TBI) dose de-escalation study"
  • Jakub Tolar, M.D., Ph.D.: "Mesenchymal stem cells ameliorate murine progeria phenotype"